Tag
Tag: Cellectis
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
The Billion-Euro European Biotech Companies in 2018
French Biotech Develops a New Generation of Safer CAR-T Cells
French CAR-T Developer Raises $164M Despite a Challenging Road
The Most Important Battle in Gene Editing: CRISPR versus TALEN
French Biotech Gets a CRISPR Patent for CAR-T Research
Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad
An Update on What’s New in the French Biotech Industry
The Biggest Biotech News of 2017: What Happened This Year?
